Home - COVID-19 Publishers Open Letter of Intent – Rapid Review
On 27 April 2020, a group of publishers and scholarly communications organisations announced a joint initiative to maximize the efficiency of peer review, ensuring that key work related to COVID-19 is reviewed and published as quickly and openly as possible. OASPA fully supports this collaborative approach and is pleased to host the Open Letter of Intent below.
27 April 2020 (updated 17 December 2020)
The COVID-19 pandemic has created a new urgency to openly and rapidly share and review COVID-19 research.
We, a group of publishers and scholarly communications organizations, are committing to work together on a cross-publisher rapid review and review transfer initiative. With the endorsement of the Open Access Scholarly Publishers Association (OASPA) we are making the following calls to reviewers, editors, authors, and publishers in the research community, in order to maximize the efficiency and speed of the triage and peer review process of COVID-19 research.
To reviewers and authors:
To publishers and editors:
This call is in addition to supporting these Wellcome Trust-coordinated calls: “Sharing research data and findings relevant to the novel coronavirus (COVID-19) outbreak” and “Publishers make coronavirus (COVID-19) content freely available and reusable”.
Signatories:
eLife, F1000 Research, Hindawi, PeerJ, PLOS, Royal Society, FAIRsharing, Outbreak Science Rapid PREreview, GigaScience, Life Science Alliance, Ubiquity Press, UCL, MIT Press, Cambridge University Press, BMC, RoRi and AfricArXiv
Downloadable PDF of this Letter of Intent (updated January 2021)
For further information on the group and/or to get involved, please contact:
OASPA
Prins Willem-Alexanderhof 5
2595BE The Hague
Netherlands
Website designed and developed by Studio Seventeen Ltd.